AI news today: agent pricing, rare disease diagnosis, and China's local-model push

Short summary

OpenAI advances rare disease diagnosis using AI to narrow search space for physicians. Anthropic pauses costly agent billing after developer pushback, exposing pricing instability. Market shifts to three competing challenges: local-model control, agent cost transparency, and security threats from tools developers depend on.

• •Rare disease diagnosis: AI assists physicians narrowing complex cases, not replacing medical judgment
• •Agent pricing unstable; token-based costs need visibility and forecasting before production deployment
• •AI infrastructure fragmenting: local models, hardware control, and attacker capabilities rival model capability race

Generated with AI, which can make mistakes.